SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Funds and ETFs Shanghai Shyndec Pharmaceutical Co., Ltd.
Equities
600420
CNE000001JG2
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.61 CNY | -0.66% |
|
+1.14% | +8.38% |
| 16/04 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
| 15/04 | China stocks rise after new guidelines; HK shares drop | RE |
ETFs positioned on Shanghai Shyndec Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products are antibiotics, circulatory system drugs and biological products, including garlic oil soft capsules, lecithin soft capsules and deep-sea fish oil soft capsules. Its bulk pharmaceutical chemicals (BPCs) include macrolide antibiotics, antiviral, anti-tumor, cardiovascular, hormones and weight loss drugs. The Company also offers topical preparations, such as gynecological suppositories and dermatology preparations.
Sector
Pharmaceuticals
Calendar
30/04/2024
- Q1 2024 Earnings Release
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
10.61
Average target price
-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.38% | 1.96B | |
| +3.96% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +3.90% | 1.65B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- 600420 Stock
- Funds and ETFs Shanghai Shyndec Pharmaceutical Co., Ltd.
